The outlook issued last Aug was "Targeting FY19 revenue of approx $260m and EBITDA of approx $36m"
Then at the AGM they stated revenue was ahead of budget, but operating costs were ~30%, against target 26%.
The strategic review announcement has added further uncertainty and caution.
So there is a certain level of downgrade already built into the current share price.
I don't expect the announcement is related to a goodwill impairment, as that would not impact on EBITDA.
The outlook issued last Aug was "Targeting FY19 revenue of...
-
- There are more pages in this discussion • 4 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add PGC (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
44.0¢ |
Change
0.020(4.76%) |
Mkt cap ! $728.3M | |||
| Open | High | Low | Value | Volume |
| 42.5¢ | 44.5¢ | 42.5¢ | $861.6K | 1.972M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 111901 | 42.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 44.5¢ | 51934 | 3 |
View Market Depth
| Last trade - 16.10pm 27/09/2024 (20 minute delay) ? |
| PGC (ASX) Chart |